Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber, +14

JAMA Oncology

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, +13

JAMA Oncology

Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, +9

European Urology

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber, +15

Cancer Research

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Archana Anantharaman, Terence W. Friedlander, David Lu, +13

BMC Cancer

Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells

Yujun Wang, Ernest Han, Quanhua Xing, +12

Cancer Letters

Tumor BiologyMtor InhibitionMedicinePharmacologyCancer Cell Biology +10

Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival

Daniel J. Boffa, Ryon P. Graf, Michelle C. Salazar, +14

Cancer Epidemiology Biomarkers & Prevention

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

Anna Truini, Jacqueline H. Starrett, Tyler F. Stewart, +12

Clinical Cancer Research

Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations

Iris K. van Alderwerelt van Rosenburgh, David Lu, Michael J. Grant, +8

Nature Communications

Beta Adrenergic Control of Extrarenal Potassium Disposal

Margaret J. Bia, David Lu, Karen Tyler, +1

˜The œNephron journals/Nephron journals